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868OBJECTIVE: The objective of this study was to develop a logic
process model (Asthma Care Model; ACM) that explains how
patient and HCP behaviors impact on the asthma care process.
METHODS: Within a European research project on asthma
(ASTRO-LAB), we reviewed asthma care guidelines and
empirical literature, and conducted qualitative interviews with
patients and HCPs. Findings were discussed with the project
team and respiratory care experts and integrated in a causal
model.
RESULTS: The model outlines a causal sequence of treatment
events, from diagnosis and assessment to treatment prescription,
drug exposure, and health outcomes. The relationships between
these components are moderated by patient behaviors
(medication adherence, symptom monitoring, managing
triggers, and exacerbations) and HCP behaviors (medical care
and self-management support). Modiﬁable and nonmodiﬁable
behavioral determinants inﬂuence the behaviors of patients and
HCPs. The model is dynamic as it includes feedback loops of
behavioral and clinical outcomes, which inﬂuence future patient
and HCP decision making. Key evidence for each relationship is
summarized to derive research priorities and clinical
recommendations.
CONCLUSIONS: The ACM model is of interest to both
researchers and practitioners, and intended as a ﬁrst version
(ACM-v1) of a common framework for generating and
translating research evidence in asthma care.  2016 The
Authors. Published by Elsevier Inc. on behalf of the American
Academy of Allergy, Asthma & Immunology. This is an open
access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/). (J Allergy Clin
Immunol Pract 2016;4:868-76)
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ACM- Asthma care model
HCP-Health care professionalHRQoL- Health-related quality of life
IM- Intervention mappingSAE- Severe asthma exacerbationManaging asthma is a challenging task as it requires sustained
performance of numerous behaviors from patients, their care-
givers, and the health care professionals (HCPs) involved in their
care. To support patients effectively in achieving and maintain-
ing asthma control, HCPs need to monitor and intervene in a
complex causal process, and to base their decisions on the latest
research evidence regarding an ever-increasing number of treat-
ment options, self-management strategies, technological ad-
vances, and health care policies. Advising patients on appropriate
medication adherence strategies is part of this process. To be
valuable for clinical practice, research needs to be conducted and
disseminated in a standardized and easily interpretable manner
and to provide accurate information on the whole domain of
interest. However, recent reviews of adherence research high-
lighted study heterogeneity and substantial knowledge gaps.1,2
The lack of a uniﬁed and comprehensive overview of the
asthma care process is not by itself a limitation of individual
studies, but can be a barrier to effective care. Individual studies
are, necessarily, constrained by the need to focus on speciﬁc
concepts and relatively simple models that can be tested within
the boundaries of 1 study. Expectedly, most observational
asthma research uses cross-sectional designs and targets a limited
number of concepts selected based on data availability rather
than on theoretical considerations.1 Experimental designs,
although highly valued for their capacity to isolate the effect of a
single causal element (eg, medical compound, behavioral inter-
vention, care protocol), have been criticized for their low external
validity when compared with routine care, which often involves a
more complex causal network.3 Aligning research hypotheses
with questions relevant for real-life practice is a priority for
asthma care, and medical care in general. Although individual
studies can optimize their clinical impact to some extent,4
building a uniﬁed picture of asthma care requires a separate
process of reviewing evidence and clinical guidelines, studying
current practice, and dialogue within the research and clinical
community to reach and update consensus on essential causal
relationships that require testing. This process would help
generate not only a comprehensive model of asthma care, but
also standardized methods for testing common research
hypotheses.
This article proposes such a model, developed within the
ASTRO-LAB project, a European Union-funded project inves-
tigating adherence to inhaled medication in asthma.5 We
describe model components and hypothesized causal relations,
and derive an agenda for asthma care research that would
maximize its value for clinical practice. The model is presented as
a ﬁrst version that would beneﬁt from further input from clini-
cians, researchers, policy makers, and patients. We hope to
stimulate collaboration and focus that would facilitate more rapid
accumulation of evidence.METHODS
We conducted reviews of asthma treatment guidelines,6-10 liter-
ature reviews, qualitative interviews, and behavior analysis of the
asthma care process with input from the study team and respiratory
care experts. Results from the guidelines review were complemented
with focused scoping reviews on speciﬁc topics, such as HCP asthma
care support, patient self-management (eg, medication adherence,
trigger management, exacerbation management), and asthma out-
comes (eg, control, exacerbations); and a systematic review on de-
terminants of medication adherence in asthma.1 Keyword searches
were conducted in EMBASE, Medline, PsychInfo, and PsychArticles
until July 2012 (the ASTRO-LAB set-up phase) using terms such as
asthma, adherence, and determinant. Articles were selected if they
reported empirical studies or narrative or systematic reviews on these
topics. References of selected articles were examined for additional
relevant works.
Qualitative interviews were conducted by telephone with pa-
tients, parents of children with asthma, and general practitioners and
nurses involved in asthma care (13 interviews in France, 26 in the
United Kingdom), as part of patient and public involvement in
research. Participants were recruited via patient and professional
organizations, and convenience sampling; no additional selection
criteria were speciﬁed. The discussions were based on semistructured
interview guides that included questions for HCPs on how they
deliver medical and behavioral asthma care and their perceptions on
patient behaviors and determinants, and barriers and facilitators to
providing asthma care; patients and/or parents were invited to share
their perceptions of the asthma care needed and received, and their
asthma management behaviors and beliefs. Results were audio-
recorded, summarized qualitatively, and used to interpret research
evidence in light of patient, caregiver, and HCP experiences, and to
analyze the asthma care process from a behavioral perspective based
on health behavior theory and principles in line with the Interven-
tion Mapping (IM) approach.11 Links between components were
formulated as causal relationships consistent with existing theory,
evidence, and clinical observation. The model was developed itera-
tively via discussions with the ASTRO-LAB team and respiratory
care experts, in which model versions were presented and feedback
requested on its components, relationships, and general format. The
research literature published during and after model development
was integrated within the relevant model components and
relationships.
RESULTS
The model
The asthma care logic model (ACM-v1; Figure 1) distin-
guishes between 3 categories of components: the asthma man-
agement process, the patient and/or caregiver’s roles, and the
HCP’s contributions to this process. Each category is brieﬂy
described below, followed by a review of the available research
evidence for the key model components, and the associated
implications for research and clinical practice.
The asthma management process. The causal sequence
of asthma management is well known to respiratory care prac-
titioners and can be formulated in simple terms as the following
sequence of events. The process of managing a person’s asthma is
prompted initially by an acute and spontaneous change in
symptoms such as wheezing, breathlessness, chest tightness, and
cough, indicating the onset of asthma at a given level of asthma
severity (a). These symptoms lead the patient to consult an HCP
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FIGURE 1. The logic model of asthma care (ACM-v1)—graphical representation.
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a speciﬁc level of severity (b). This guides the HCP to recommend
a corresponding regimen of prescribed drug exposure (c), which
should determine the patient’s actual drug exposure (d) and
together with reducing trigger exposure (f), should increase asthma
control (e). Patients with controlled asthma and a limited expo-
sure to triggers have a reduced risk of severe asthma exacerbations
(SAEs) (g). Both controlled asthma and reduced SAE contribute
to increased health-related quality of life (HRQoL) (h). This causal
sequence is the implicit standard for asthma management, yet in
real life it is subject to various inﬂuences that may weaken the
strength of these causal links. These inﬂuences are conceptualized
here as moderators, and described in terms of patients and/or
caregivers’ behaviors and HCPs’ behaviors. Interventions to opti-
mize asthma management in clinical practice are, in essence,
efforts to modify these parameters to achieve maximum strength
of association in this causal sequence. Understanding their role is
therefore essential for asthma care.
The patients and caregivers. The model includes 4
groups of patient behaviors necessary for managing asthma:
adherence to regular and correct use of controller inhalers (i),
symptom monitoring (j), trigger management (k), and SAE man-
agement (l). These behaviors can be the sole responsibility of
patients, or can be shared between patients and caregivers (eg,
parents of children with asthma). Inhaler adherence moderates the
relationship between prescribed and actual drug exposure: pa-
tients need to inhale the drug in the quantity and at the intervals
recommended, and perform the inhalations correctly. Not
initiating treatment, modifying the dosage or timing of admin-
istration, interrupting or discontinuing treatment, and subopti-
mal inhalation technique can weaken or even sever the causal
link between prescription and exposure. Trigger and SAE man-
agement behaviors act on the subsequent components of theasthma management process. Trigger management can directly
reduce trigger exposure by avoidance behaviors (eg, removing
allergens from the immediate environment) or can moderate the
relationship between trigger exposure and SAE occurrence by
remedial behaviors (eg, reliever inhaler use). SAE management
behaviors (eg, using reliever inhalers, administering nebulized
medication, requesting emergency services) can reduce the
severity and duration of an SAE, and thus inﬂuence the impact of
an SAE on the patient’s HRQoL. Self-monitoring of asthma
symptoms (symptom monitoring) offers patients feedback on the
effects of prior behaviors, and thus inﬂuences asthma outcomes
indirectly via medication adherence and trigger management.
These 4 types of behaviors are in turn inﬂuenced by a set of
behavioral determinants (m). These can be modiﬁable factors (eg,
knowledge about adherence, illness beliefs, self-regulation skills)
or nonmodiﬁable characteristics (eg, sociodemographics). As
patient behaviors are essential to the success of asthma treat-
ments, understanding what drives these behaviors is key to
enhancing effective self-management.
The health care professionals. Health care services can
inﬂuence asthma management in 2 main areas: directly on the
asthma management process via medical care (n), and indirectly
on caregiver and patient behaviors via behavioral care (o). The
quality of medical care can be conceptualized as behaviors that
strengthen the association between intrinsic and assessed asthma
severity (ie, accurate diagnosis and review); and between assessed
severity and prescribed drug exposure (ie, prescribing the
appropriate treatment for the asthma severity level identiﬁed).
The model stipulates that medical care is a necessary but not
sufﬁcient condition for treatment success. Behavioral care (also
known as therapeutic education or self-management support)
can have a major impact on treatment outcomes through inﬂu-
encing patient self-management. The model speciﬁes that HCPs
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management behaviors through, for example, training inhaler
technique, providing individualized asthma action plans, or
assistance in identifying triggers. The performance of both
medical and behavioral care is, just as for patients, inﬂuenced by
behavioral determinants (p). These can be modiﬁable factors (eg,
HCPs’ medical knowledge, communication skills, or access to
training, equipment, and treatments), or nonmodiﬁable (eg,
specialty, gender, age).
Feedback loops. The role of accurately assessing treatment
outcomes and patients’ behaviors in asthma care is modeled as 2
types of feedback loops between these components and HCPs’ and
patients’ behavior determinants. To the extent that feedback on
health outcomes is regularly incorporated in follow-up consulta-
tions, it can have a positive effect on medical care as it informs
the adjustment of asthma severity and corresponding treatment
plan (step-up or step-down asthma severity and treatment pre-
scription). Feedback on patient behaviors is also required for the
correct interpretation of any changes in health outcomes and
deciding which link in the causal sequence of asthma care is the
best target for intervention. Similarly, patients would beneﬁt in
principle from assessing the effects of their behaviors regularly
and using this information to adjust their behavior if needed.
Research evidence, and implications for research
and clinical practice
Developing the logic model enabled the conceptual categori-
zation of the research literature in terms of its relevance for
speciﬁc model components and relationships. Interpreted within
this framework, the evidence points to speciﬁc research and
clinical implications outlined in Table I and summarized below.
From intrinsic to assessed severity (1). Performing
guideline-recommended activities such as applying comprehen-
sive algorithms combining clinical assessment with objective tests
is known to improve the accuracy of assessed asthma severity,12
speciﬁed here as a moderating role of medical care on the link
between intrinsic and assessed asthma severity. The assessment of
severity remains a challenge, as asthma severity has proven
difﬁcult to deﬁne and measure, particularly to distinguish from
asthma control.13,14 Moreover, asthma misdiagnosis is still
common, objective tests are often underused, and low agreement
levels between HCPs are reported regarding diagnosis15-18
despite several promising initiatives for improving diagnosis ac-
curacy.19,20 For adherence research, this implies that the accuracy
of asthma severity assessment should ideally be accounted for or
reviewed in study participants, as subsequent causal links may be
weakened or severed by over- or underestimated severity.
Improving the assessment of severity is a priority in asthma
research. For the practitioner, reviewing asthma severity regularly
via multiple guideline-recommended methods is a precondition
for effective asthma care, as it allows a meaningful contribution
of other patient, caregiver, and HCP behaviors.
From assessed severity to prescribed drug exposure
(2). Asthma guidelines provide evidence-based treatment rec-
ommendations according to asthma severity steps, but HCP
guideline nonadherence remains a challenge for asthma care.21-23
Interventions for improving implementation of best practices
show limited effects24-26 and better strategies need to be devel-
oped and tested. Adherence studies need to assess and take intoaccount prescribing practices. For practice, applying the stepwise
approach to treatment prescription and reviewing prescribed
treatment regularly to accommodate any changes in control
would help tailor prescribed treatment to the appropriate asthma
severity levels.9
From prescribed to actual drug exposure—adherence
and inhaler technique (3). If assessment and prescription
are appropriate, a good correspondence between the prescribed
and actual exposure would ensure an optimal treatment effect.
For inhaled medication, achieving the prescribed drug exposure
involves adhering to recommendations regarding both use
(timing and dosing) and technique (correct device use). When
patients use inhalers less than prescribed and/or with poor
technique, which often happens in practice,27-29 this corre-
spondence is reduced or nonexistent, with a negative impact on
health.2,30-32 The assessment of use and technique in research
and clinical practice is usually based on scarce and less accurate
information. Although electronic monitoring is the gold stan-
dard, its broader implementation still represents a challenge, and
most studies rely on self-report or prescription and/or dispensing
records29,33 with few studies using multiple data sources.34,35
Inhaler use is commonly evaluated via clinician checklist-based
observation,27,36 and only recently an integrated assessment of
both aspects was developed that allows a more accurate assess-
ment of their impact on actual versus prescribed drug exposure.37
Given these considerations, both research and clinical practice
should aim for comprehensive assessment of both use and
technique, and tool development should continue to improve
measurement validity and reliability.
The impact of trigger exposure and management on
asthma outcomes (4). Guidelines recommend a systematic
assessment of salient asthma triggers and enabling patients to
manage triggers to improve asthma control.6-10 Although the role
of environmental triggers in asthma is well known and managing
triggers has been linked to improved health outcomes,38,39
trigger management has been less integrated in behavioral in-
terventions and routine care.40,41 Trigger sensitivity and expo-
sure are rarely assessed in research and practice although valid
instruments exist.42,43 Research investigating the impact of
adherence on asthma outcomes would ideally incorporate
assessment of trigger exposure and trigger management actions
performed, which would allow disentangling the impact of
adherence from the role of triggers. In clinical practice, identi-
fying salient triggers, inquiring systematically about possible
exposure to triggers, and advising on strategies to avoid or reduce
their impact could strengthen the impact of actual drug exposure
on health outcomes.
The role of symptom monitoring (5). Recognizing
symptoms and signs of deterioration is essential for managing
asthma, because it guides remedial actions such as reliever use
and trigger management; clinicians are encouraged to promote
regular symptom monitoring as part of guided self-manage-
ment.9 Research on monitoring as a behavior in itself is however
scarce and focuses on the effect of regular peak ﬂow or symptom
diary use on distal health outcomes44-47 and rarely on proximal
remedial behaviors.48 Future research needs to investigate the
role of symptom monitoring in asthma self-management and its
association with other patient and/or caregiver behaviors. In
TABLE I. The logic model of asthma care (ACM-v1)—summary of research evidence and implications for research and clinical practice
No. Model component What the literature shows Research implications Clinical implications
1 The relationship between intrinsic severity and
assessed severity depends on the quality of
medical care
Guideline-recommended care improves
assessment accuracy; asthma severity proves
difﬁcult to deﬁne and measure; asthma
misdiagnosis is still common; objective tests
are underused; low agreement exists
between HCPs
Take into account assessment accuracy in
studies linking adherence and health
outcomes; improve measurement of asthma
severity
Assess and review asthma severity regularly
via multiple guideline-recommended
methods
2 The relationship between assessed severity and
prescribed drug exposure depends on the
quality of medical care
HCP nonadherence to guideline-recommended
medication prescription remains a challenge;
guideline implementation interventions are
suboptimal
Develop and test new strategies for
implementation of best practices; assess and
take into account prescribing practices in
adherence studies
Follow guideline-recommended step-wise
approach to treatment prescription
3 The relationship between prescribed and actual
drug exposure depends on patient and/or
caregiver’s regular use of medication and the
correct use of inhaler devices
For inhaled treatment, medication use
recommendations refer to dosing, timing,
and device use; in asthma, these are often
suboptimal, with negative impact on health;
assessment of inhaler use and technique in
research and clinical practice rely usually on
scarce information
Consider using multiple tools to assess both
use and technique; further develop electronic
monitoring instruments to capture ﬁne-
grained data on adherence and thus on the
link between prescribed and actual exposure
Assess both inhaler technique and use via state-
of-the-art instruments to understand the link
between prescribed and actual drug
exposure
4 Trigger management inﬂuences trigger
exposure and subsequently health outcomes
Trigger management is seldom addressed in
routine care; there is limited research on its
role on trigger exposure and health
outcomes
Measure trigger management and exposure in
adherence studies; investigate trigger
management behaviors and their role in
managing asthma
Identify relevant triggers and ask patients about
exposure to these triggers to assess their
impact on asthma control and SAE
occurrence; check what strategies patients
use to avoid or reduce the impact of relevant
triggers
5 Symptom monitoring inﬂuences both
adherence and trigger management
Symptom monitoring is a key component of
guideline-recommended management; there
is limited research on its effects, especially
on adherence and trigger management
More research is needed on the role of
symptom monitoring in asthma self-
management in relation to adherence and
triggers
Check if symptomatic patients use accurate
methods to monitor symptoms and how they
use this information to optimize adherence
and trigger management
6 SAEs impact on patients’ HRQoL, depending
on how well they manage SAEs when they
occur
Frequent SAEs impact on HRQoL; the degree
to which SAE management by patients
moderates the consequences of SAE is
understudied
More research is needed on SAE management
behaviors, and their role in managing asthma
Assess SAE and their impact on patients
HRQoL, and what strategies patients are
using to handle SAE
7 Patient and/or caregiver asthma management
behaviors are driven by nonmodiﬁable and
modiﬁable behavioral determinants, which
may be behavior-speciﬁc or inﬂuence
several behaviors
Determinants research focuses on
implementation of prescribed medication
use; their quality and theoretical basis is
often suboptimal; limited evidence exists on
determinants of other patient behaviors, and
on caregiver behaviors
Investigate determinants of all patient and
caregiver asthma management behaviors
using state-of-the-art methodology and
theory
Assess patients’ knowledge, beliefs and/or
motivation, self-management plans and/or
strategies and skills, social support and/or
perceived stigma in relation to performing
key self-management behaviors
8 Behavioral care is the support delivered by
HCPs to promote optimal asthma
management by patients and caregivers
HCPs’ adherence to guideline
recommendations on behavioral care is low;
effective self-management interventions are
less implemented in routine care
Assess behavioral care in study settings to
estimate its impact on asthma management
Support patient and caregiver behaviors by
identifying and addressing key determinants
of self-management
9 Modiﬁable and nonmodiﬁable factors inﬂuence
the quality of medical and behavioral care
Internal and external inﬂuences on quality of
care have been identiﬁed, but most studies
show little theory use
Adapt theory-based models of HCP behavior
from the implementation literature
Maintain professional training and identify
gaps in knowledge and/or skills to identify
training needs
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DIMA ETAL 873clinical practice, asthma outcomes would be further improved by
advising patients on using accurate methods to monitor symp-
toms to optimize adherence and trigger management.
SAE management as moderator of SAE effects on
HRQoL (6). Guidelines recommend advising patients on
appropriate symptom management actions when symptoms in-
crease, including use of reliever inhalers and accessing emergency
care, as part of personalized action plans.6-10 Research demon-
strated that frequent SAEs affect HRQoL negatively,49,50 and
health care utilization behaviors during SAE inﬂuence the success
of medical interventions.51 Yet, evidence in this area is scarce.
Future research needs to isolate effective SAE management be-
haviors and their speciﬁc contribution in managing asthma. In
clinical practice, inquiring about patients’ SAE management
strategies is necessary to assess the potential impact of SAEs on
patients’ HRQoL; educating patients on best strategies may
reduce the effect of SAEs on patients’ lives.
Determinants of patient and/or caregiver asthma
management behaviors (7). An increasing body of evi-
dence suggests that patient and/or caregiver asthma management
behaviors are driven by nonmodiﬁable and modiﬁable behavioral
determinants in both adults1 and children.52 These may be
behavior-speciﬁc (eg, treatment beliefs inﬂuencing medication
implementation53) or inﬂuence several behaviors (eg, illness be-
liefs54). However, the quality and theoretical basis of studies is
often suboptimal,1 and evidence is limited on determinants
speciﬁc to inhaler technique, symptom monitoring, triggers, and
SAE management. To our knowledge, no study has examined
the impact of common determinants on multiple behaviors.
Evidence on determinants of caregiver behaviors is also scarce
and mostly focused on individual characteristics, and less on
interactive processes.55-57 There is an urgent need for high-
quality, theory-informed studies on the determinants of all
asthma management behaviors. In clinical practice, assessing
patients’ and caregivers’ knowledge, motivation, and skills on
managing their asthma (eg, as part of therapeutic patient edu-
cation) would allow understanding the modiﬁable causes of
suboptimal self-management.
Behavioral care targets patient and/or caregiver
behavioral determinants (8). To promote optimal asthma
management, HCPs need to perform speciﬁc behavioral care
activities that target indirectly patient and/or caregiver behaviors
via behavioral determinants. Although diagnosis and prescribing
practices have been extensively investigated, research on asthma
self-management support practices is limited, and focuses on
either HCP guideline adherence23,58-61 or developing self-
management interventions.62,63 Research into causes of medi-
cation adherence would also need to map the behavioral content
of self-management support in current routine care and estimate
its contribution to treatment outcomes. Supporting self-
management via multiple activities (eg, developing individual
action plans, demonstrating the correct inhaler use, encouraging
reminders use) needs to be integrated in routine asthma care.
Determinants of HCP asthma care behaviors (9). The
quality of routine medical and behavioral care is determined by
modiﬁable and nonmodiﬁable factors that can be internal (eg,
knowledge, motivation, skills)58,59,64-67 or external (eg, time per
patient, ﬁnancial incentives).59,64,66,68,69 Prior studies show
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874 DIMA ETALlimited use of behavioral theory, despite widespread recognition
of its value in implementation research.70-72 Further research is
needed to adapt existing HCP behavior models to asthma care.
For clinicians, maintaining professional training on both medical
and behavioral care would facilitate the provision of high-quality
care.
Feedback from health outcomes and patient and/or
caregiver behaviors (10). Clinical guidelines recommend
assessment of patient behaviors to guide interpretation of treat-
ment effects on asthma outcomes.6-10 For example, compre-
hensive feedback can guide the clinician to target suboptimal
drug exposure via medical care (eg, reconsider treatment via
shared decision making73,74) or/and behavioral care (eg, improve
inhaler technique via guided practice or inhaler adherence via
reviewing recent inhaler use and discussing adherence-related
barriers and goals75,76). It is yet unclear whether comprehen-
sive feedback is obtained in routine care, and what is its impact
on decision making for HCPs and patients and/or caregivers.
Research needs to identify how behaviors and outcomes are
assessed and interpreted jointly to inform decision making. Be-
haviors and behavioral outcomes need to be routinely assessed
and combined to arrive at accurate interpretations of asthma
outcomes.
DISCUSSION
Based on guidelines, empirical literature, and patient, HCP,
and expert input, a logic model of asthma care (ACM-v1) has
been developed that highlights the contributions of patient,
caregiver, and HCP behaviors to the causal sequence of asthma
management. The ACM-v1 represents a much-needed contri-
bution to asthma care, as it allows a theory-based integration of
research and clinical care through several possible practical ap-
plications. First, it can be used to identify key gaps in our un-
derstanding of asthma management, and thus guide the focus of
researchers and funders. Second, it can help researchers improve
study design by guiding the selection of concepts and hypotheses
to balance theoretical considerations with the resources available.
In the ASTRO-LAB project,5 for example, the ACM-v1 guided
the selection of measurement tools and data collection pro-
cedures to allow insights into the asthma management process as
well as patient, caregiver, and HCP behaviors and determinants.
Third, HCPs can apply ACM-v1 to better understand the
complex behavioral inﬂuences on asthma care, and select speciﬁc
medical or behavioral care activities based on their expected
impact on the process. Fourth, for those developing behavioral
interventions to improve asthma care, ACM-v1 can guide the
initial phase of needs assessment, based on which further work
may select intervention objectives, behavior change methods, and
produce program content, implementation, and evaluation pro-
cedures.11,77 Hence, ACM-v1 could beneﬁt the organization and
advancement of both asthma care research and clinical practice.
ACM-v1 is ready for use in clinical care in 2 ways. First, the
clinical implications outlined in Table I are adaptable to checklist
or interview guide format to audit current practice, and can be
used by clinicians and management staff to identify current
strengths and goals for improvement in asthma care delivery in
line with asthma guidelines. Second, clinicians may use the
graphical representation of ACM-v1 as a case management tool
to ensure that all relevant medical and behavioral support has
been taken into account when providing care and interpretingtreatment outcomes (eg, ascertain to what extent poor outcomes
may be due to treatment decisions or patient behaviors).
Moreover, it represents a framework in which communication
tools for guideline implementation can be developed, and up-
dates of asthma management guidelines can structure practice-
based and research input and formulate recommendations and
research needs. These practical applications await further testing.
The current ACM version is limited by the contextual con-
straints of its development—for use within the ASTRO-LAB
study and predeﬁned timelines—and by the availability of
empirical data on speciﬁc components. Given the study focus on
routine asthma care in a speciﬁc sociocultural context, the model
selects primary moderators of asthma management and excludes
details on each of these components, roles of other actors (eg,
policy makers, administrators, or product developers), or health
economic components. In line with IM methodology, it is
designed to be complemented by speciﬁc determinant maps,
which may depend on the characteristics of target groups (eg,
age, health literacy, cultural context). Similarly, cost implications
can be superposed on model components, following IM-based
procedures for intervention evaluation. Moreover, ACM as-
sumes a relatively stable model structure across different asthma
populations, which requires further testing. Our targeted litera-
ture reviews indicated limited evidence for some components and
therefore ACM-v1 would beneﬁt from new empirical studies,
which might conﬁrm or suggest improvements of the model.
Further systematic reviews and expert consensus studies are
necessary to strengthen the model.
ACM-v1 represents an initial proposal for an integrative
theoretical framework of asthma care combining medical and
behavior change principles, and aims to facilitate the translation
of research into clinical practice of the management of asthma, as
an example of chronic (respiratory) condition. As such, it opens
opportunities for improvement or adaptation to different
research contexts and respiratory conditions.
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